SK280967B6
(sk)
*
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Inhalačný prístroj
|
UA26230A
(uk)
*
|
1990-03-02 |
1999-07-19 |
Глексо Груп Лімітед |
Іhгалятор для спільhого використаhhя з лікувальhим блоком і лікувальhий блок
|
US6055980A
(en)
*
|
1991-05-20 |
2000-05-02 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5785049A
(en)
*
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
WO1996009085A1
(en)
*
|
1994-09-21 |
1996-03-28 |
Inhale Therapeutic Systems |
Apparatus and methods for dispersing dry powder medicaments
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US5645051A
(en)
*
|
1995-04-21 |
1997-07-08 |
Dura Pharmaceuticals, Inc. |
Unit dose dry powder inhaler
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5669973A
(en)
*
|
1995-06-06 |
1997-09-23 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing and retaining materials upon a substrate
|
US5714007A
(en)
*
|
1995-06-06 |
1998-02-03 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
|
US6672304B1
(en)
|
1995-06-08 |
2004-01-06 |
Innovative Devices, Llc |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
US20040237961A1
(en)
*
|
1995-06-08 |
2004-12-02 |
Snow John Medlin |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
DE19523516C1
(de)
*
|
1995-06-30 |
1996-10-31 |
Asta Medica Ag |
Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
|
US5642727A
(en)
*
|
1995-07-25 |
1997-07-01 |
David Sarnoff Research Center, Inc. |
Inhaler apparatus using a tribo-electric charging technique
|
US5875776A
(en)
*
|
1996-04-09 |
1999-03-02 |
Vivorx Pharmaceuticals, Inc. |
Dry powder inhaler
|
AU724503B2
(en)
*
|
1996-04-29 |
2000-09-21 |
Dura Pharmaceuticals, Inc. |
Methods of dry powder inhalation
|
US5871010A
(en)
*
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
US5794613A
(en)
*
|
1997-01-09 |
1998-08-18 |
Sepracor, Inc. |
Multiple-dose dispenser for dry powder inhalers
|
TW469832U
(en)
*
|
1997-03-14 |
2001-12-21 |
Astra Ab |
Inhalation device
|
SE9700937D0
(sv)
*
|
1997-03-14 |
1997-03-14 |
Astra Ab |
Powder inhaler I
|
US6006747A
(en)
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US5954047A
(en)
*
|
1997-10-17 |
1999-09-21 |
Systemic Pulmonary Development, Ltd. |
Methods and apparatus for delivering aerosolized medication
|
US6237591B1
(en)
|
1998-11-02 |
2001-05-29 |
Dura Pharmaceuticals, Inc. |
Turbine dry powder inhaler
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
AU746970B2
(en)
|
1997-12-02 |
2002-05-09 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US6192876B1
(en)
|
1997-12-12 |
2001-02-27 |
Astra Aktiebolag |
Inhalation apparatus and method
|
US6352722B1
(en)
|
1997-12-23 |
2002-03-05 |
Quadrant Holdings Cambridge Limited |
Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
|
US6004268A
(en)
*
|
1998-04-21 |
1999-12-21 |
Addington; W. Robert |
Aspiration screening process for assessing post surgery patient's risk for pneumonia
|
US6257233B1
(en)
|
1998-06-04 |
2001-07-10 |
Inhale Therapeutic Systems |
Dry powder dispersing apparatus and methods for their use
|
US6149774A
(en)
|
1998-06-10 |
2000-11-21 |
Delsys Pharmaceutical Corporation |
AC waveforms biasing for bead manipulating chucks
|
SE512386C2
(sv)
*
|
1998-07-30 |
2000-03-06 |
Microdrug Ag |
Förfarande och anordning för klassificering av elektrostatiskt laddat pulverformigt material
|
UA73924C2
(en)
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
FR2787031B1
(fr)
*
|
1998-12-11 |
2001-03-30 |
Valois Sa |
Dispositif d'inhalation ameliore
|
AU771984B2
(en)
|
1998-12-22 |
2004-04-08 |
University Of North Carolina At Chapel Hill, The |
Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
|
US6923979B2
(en)
*
|
1999-04-27 |
2005-08-02 |
Microdose Technologies, Inc. |
Method for depositing particles onto a substrate using an alternating electric field
|
AU779986B2
(en)
|
1999-06-29 |
2005-02-24 |
Mannkind Corporation |
Purification and stabilization of peptide and protein pharmaceutical agents
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US7464706B2
(en)
*
|
1999-07-23 |
2008-12-16 |
Mannkind Corporation |
Unit dose cartridge and dry powder inhaler
|
US7305986B1
(en)
|
1999-07-23 |
2007-12-11 |
Mannkind Corporation |
Unit dose capsules for use in a dry powder inhaler
|
US6679256B2
(en)
|
1999-12-17 |
2004-01-20 |
Nektar Therapeutics |
Systems and methods for extracting powders from receptacles
|
US6651655B1
(en)
*
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
AU2001234005B2
(en)
|
2000-02-28 |
2006-01-19 |
Pharmakodex Limited |
Improvements in or relating to the delivery of oral drugs
|
US20040115133A1
(en)
*
|
2000-05-10 |
2004-06-17 |
Wermeling Daniel P. |
Intranasal opioid compositions
|
AU6124601A
(en)
|
2000-05-10 |
2001-11-20 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US20030003057A1
(en)
*
|
2000-07-07 |
2003-01-02 |
Jeffry Weers |
Methods for administering leuprolide by inhalation
|
US6610271B2
(en)
*
|
2000-05-10 |
2003-08-26 |
University Of Kentucky Research Foundation |
System and method for intranasal administration of lorazepam
|
US6948494B1
(en)
|
2000-05-10 |
2005-09-27 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet and method of use
|
US20060083691A1
(en)
*
|
2000-05-10 |
2006-04-20 |
Wermeling Daniel P |
Intranasal opioid compositions, delivery devices and methods of using same
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
PE20020066A1
(es)
|
2000-06-23 |
2002-02-23 |
Norton Healthcare Ltd |
Deposito de dosis medidas previamente para inhalador de polvo seco accionado por la respiracion
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
AU2001283546A1
(en)
|
2000-08-14 |
2002-02-25 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
JP2004505730A
(ja)
*
|
2000-08-15 |
2004-02-26 |
ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション |
プログラム可能多用量鼻腔内薬物送達デバイス
|
US20040176359A1
(en)
*
|
2001-02-20 |
2004-09-09 |
University Of Kentucky Research Foundation |
Intranasal Benzodiazepine compositions
|
US6766799B2
(en)
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
WO2002092154A1
(en)
|
2001-04-26 |
2002-11-21 |
New England Pharmaceuticals, Inc. |
Metered dose delivery device for liquid and powder agents
|
FI20011317A0
(fi)
|
2001-06-20 |
2001-06-20 |
Orion Corp |
Jauheinhalaattori
|
JP3619176B2
(ja)
*
|
2001-09-14 |
2005-02-09 |
オムロンヘルスケア株式会社 |
エアロゾル粒子分別装置及び吸入器
|
CA2460904C
(en)
*
|
2001-09-19 |
2011-03-22 |
Advent Pharmaceuticals Pty Ltd |
An inhaler for delivering metered doses of powdered medicament
|
JP4795637B2
(ja)
*
|
2001-09-28 |
2011-10-19 |
カーブ テクノロジー,インコーポレイティド |
鼻ネブライザー
|
CN100374457C
(zh)
|
2001-11-14 |
2008-03-12 |
森托科尔公司 |
抗il-6抗体、组合物、方法和用途
|
JP2005514393A
(ja)
|
2001-12-19 |
2005-05-19 |
ネクター セラピューティクス |
アミノグリコシドの肺への供給
|
AU2003215254A1
(en)
|
2002-02-13 |
2003-09-04 |
Immunology Laboratories, Inc. |
Compositions and methods for treatment of microbial infections
|
ES2300568T3
(es)
|
2002-03-20 |
2008-06-16 |
Mannkind Corporation |
Aparato de inhalacion.
|
JP2005533013A
(ja)
*
|
2002-04-19 |
2005-11-04 |
イスム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティ オブ エルサレム |
一酸化窒素供与基および反応性酸素種捕捉基を含有するβ作用薬化合物、ならびに呼吸障害の治療における該化合物の使用
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
US8122881B2
(en)
*
|
2002-05-09 |
2012-02-28 |
Kurve Technology, Inc. |
Particle dispersion device for nasal delivery
|
US6889690B2
(en)
|
2002-05-10 |
2005-05-10 |
Oriel Therapeutics, Inc. |
Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
|
US6985798B2
(en)
*
|
2002-05-10 |
2006-01-10 |
Oriel Therapeutics, Inc. |
Dry powder dose filling systems and related methods
|
US7118010B2
(en)
*
|
2002-05-10 |
2006-10-10 |
Oriel Therapeutics, Inc. |
Apparatus, systems and related methods for dispensing and /or evaluating dry powders
|
US7677411B2
(en)
|
2002-05-10 |
2010-03-16 |
Oriel Therapeutics, Inc. |
Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
|
WO2004002395A2
(en)
|
2002-06-27 |
2004-01-08 |
Oriel Therapeutics, Inc. |
Apparatus, systems and related methods for processing, dispensing and/or evaluating non-pharmaceutical dry powders
|
EP1545608A4
(en)
|
2002-06-28 |
2006-09-13 |
Centocor Inc |
CH1-DELETED MAMMED MUICETIC BODIES, COMPOSITIONS, METHODS AND APPLICATIONS
|
AU2003278565A1
(en)
*
|
2002-10-25 |
2004-05-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
|
TWI313181B
(en)
*
|
2002-12-13 |
2009-08-11 |
Otsuka Pharma Co Ltd |
Inhalation device for transpulmonary administration
|
GB0303870D0
(en)
*
|
2003-02-20 |
2003-03-26 |
Norton Healthcare Ltd |
Pre-metered dose magazine for breath-actuated dry powder inhaler
|
SI1663235T1
(sl)
|
2003-08-18 |
2013-12-31 |
Parion Sciences, Inc. |
Zaščiteni pirazinoilgvanidinski blokatorji natrijevega kanala
|
WO2005023334A2
(en)
*
|
2003-09-05 |
2005-03-17 |
Kurve Technology, Inc. |
Nasal adapter for the base of the nose
|
JP5144070B2
(ja)
*
|
2003-09-05 |
2013-02-13 |
カーブ テクノロジー,インコーポレイティド |
鼻腔深部及び副鼻腔に薬剤を点鼻送達するための一体型ネブライザ及び粒子分散チャンバ
|
CA2533887A1
(en)
*
|
2003-09-30 |
2005-04-14 |
Acusphere, Inc. |
Injectable, oral, or topical sustained release pharmaceutical formulations
|
UA89481C2
(uk)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
US7377277B2
(en)
|
2003-10-27 |
2008-05-27 |
Oriel Therapeutics, Inc. |
Blister packages with frames and associated methods of fabricating dry powder drug containment systems
|
US7451761B2
(en)
|
2003-10-27 |
2008-11-18 |
Oriel Therapeutics, Inc. |
Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
|
WO2005040163A1
(en)
|
2003-10-28 |
2005-05-06 |
Dr. Reddy's Laboratories Ltd |
Heterocyclic compounds that block the effects of advanced glycation end products (age)
|
JP2007517892A
(ja)
*
|
2004-01-12 |
2007-07-05 |
マンカインド コーポレイション |
2型糖尿病における血清プロインスリンレベルを低下させる方法
|
GB0400804D0
(en)
|
2004-01-14 |
2004-02-18 |
Innoscience Technology Bv |
Pharmaceutical compositions
|
US7607435B2
(en)
*
|
2004-01-21 |
2009-10-27 |
Battelle Memorial Institute |
Gas or liquid flow sensor
|
US7491194B1
(en)
|
2004-02-03 |
2009-02-17 |
David Oliwa |
Remote control valve for urine collection bag
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
WO2005097175A2
(en)
|
2004-03-31 |
2005-10-20 |
Centocor, Inc. |
Human glp-1 mimetibodies, compositions, methods and uses
|
KR20070054644A
(ko)
*
|
2004-07-26 |
2007-05-29 |
액테리온 파마슈티칼 리미티드 |
미립자 제형으로 흡입된 일로프로스트에 의한 폐고혈압의치료
|
MX2007001903A
(es)
|
2004-08-20 |
2007-08-02 |
Mannkind Corp |
Catalisis de sintesis de dicetopiperazina.
|
KR101306384B1
(ko)
|
2004-08-23 |
2013-09-09 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는디케토디옥산염
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
GB0427858D0
(en)
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427856D0
(en)
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Maniflod for use in medicament dispenser
|
ATE392251T1
(de)
|
2004-12-23 |
2008-05-15 |
Kinematica Ag |
Vorrichtung zum dispergieren eines festen, flüssigen oder gasförmigen stoffes in einer flüssigkeit
|
JO3058B1
(ar)
|
2005-04-29 |
2017-03-15 |
Applied Molecular Evolution Inc |
الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
|
JP2009501006A
(ja)
|
2005-06-30 |
2009-01-15 |
セントカー・インコーポレーテツド |
抗il−23抗体、組成物、方法および用途
|
JP5465878B2
(ja)
|
2005-09-14 |
2014-04-09 |
マンカインド コーポレイション |
活性薬剤に対する結晶性微粒子表面の親和性を増大させることに基づく薬物処方の方法
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
AR058289A1
(es)
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
CA2631493A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
HUE034269T2
(en)
|
2005-12-29 |
2018-02-28 |
Janssen Biotech Inc |
Human anti-IL-23 antibodies, preparations, methods and applications
|
CN104383546B
(zh)
|
2006-02-22 |
2021-03-02 |
曼金德公司 |
用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
|
CA2642229C
(en)
|
2006-02-24 |
2015-05-12 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
US8037880B2
(en)
*
|
2006-04-07 |
2011-10-18 |
The University Of Western Ontario |
Dry powder inhaler
|
DE102006016901A1
(de)
*
|
2006-04-11 |
2007-10-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Mundstück für einen Inhalator
|
DE102006016904A1
(de)
*
|
2006-04-11 |
2007-10-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
WO2007121256A2
(en)
|
2006-04-12 |
2007-10-25 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
JP2010500360A
(ja)
|
2006-08-10 |
2010-01-07 |
アルボア コーポレーション |
炎症性サイトカイン阻害剤による下気道炎症疾患の局所療法
|
WO2008028092A2
(en)
|
2006-08-30 |
2008-03-06 |
Kurve Technology, Inc. |
Aerosol generating and delivery device
|
TW200843794A
(en)
|
2006-12-21 |
2008-11-16 |
Centocor Inc |
Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles
|
US20080275030A1
(en)
|
2007-01-19 |
2008-11-06 |
Sveinbjorn Gizurarson |
Methods and Compositions for the Delivery of a Therapeutic Agent
|
US8496002B2
(en)
|
2007-06-12 |
2013-07-30 |
Civitas Therapeutics, Inc. |
Powder inhaler devices
|
US8785396B2
(en)
|
2007-10-24 |
2014-07-22 |
Mannkind Corporation |
Method and composition for treating migraines
|
AR070527A1
(es)
|
2008-02-26 |
2010-04-14 |
Johnson Michael R |
Bloqueadores poliaromaticos del canal de sodio
|
JP5569398B2
(ja)
|
2008-02-29 |
2014-08-13 |
フェッローサン メディカル ディバイス エー/エス |
止血および/または創傷治癒を促進するための装置
|
CA2719205C
(en)
*
|
2008-03-27 |
2017-04-25 |
Mannkind Corporation |
A dry powder inhalation system
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
JP5479465B2
(ja)
|
2008-06-20 |
2014-04-23 |
マンカインド コーポレイション |
吸入努力をリアルタイムにプロファイルする対話式機器および方法
|
WO2010008523A1
(en)
|
2008-07-13 |
2010-01-21 |
Map Pharmaceuticals, Inc. |
Methods and apparatus for delivering aerosolized medication
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
US8563697B2
(en)
|
2008-08-14 |
2013-10-22 |
Cephalon Australia Pty. Ltd. |
Anti-IL-12/IL-23 antibodies
|
CA2741834C
(en)
|
2008-10-31 |
2022-04-05 |
Centocor Ortho Biotech Inc. |
Fibronectin type iii domain based scaffold compositions, methods and uses
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
JP5802136B2
(ja)
|
2009-01-23 |
2015-10-28 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Jak経路の阻害のための組成物および方法
|
EP2396011B1
(en)
|
2009-02-12 |
2016-04-13 |
Janssen Biotech, Inc. |
Fibronectin type iii domain based scaffold compositions, methods and uses
|
JP5510968B2
(ja)
|
2009-02-23 |
2014-06-04 |
日本たばこ産業株式会社 |
非加熱型たばこ香味吸引器
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
PL2405963T3
(pl)
|
2009-03-11 |
2014-04-30 |
Mannkind Corp |
Urządzenie, układ i sposób pomiaru oporu inhalatora
|
CA3033133C
(en)
|
2009-03-25 |
2021-11-09 |
The Board Of Regents Of The University Of Texas System |
Compositions for stimulation of mammalian innate immune resistance to pathogens
|
FR2946537B1
(fr)
|
2009-06-11 |
2012-08-03 |
Valois Sas |
Dispositif d'inhalation de poudre
|
EP2440184B1
(en)
|
2009-06-12 |
2023-04-05 |
MannKind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
WO2011080761A1
(en)
|
2009-12-30 |
2011-07-07 |
Thirumalai Anadampillai Aparna |
An improved dry powder inhaler
|
CA2788078A1
(en)
|
2010-01-26 |
2011-08-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M Ltd. |
Compositions and methods for prevention and treatment of pulmonary hypertension
|
CN102933231B
(zh)
|
2010-02-10 |
2015-07-29 |
伊缪诺金公司 |
Cd20抗体及其用途
|
NZ603581A
(en)
|
2010-06-19 |
2015-05-29 |
Sloan Kettering Inst Cancer |
Anti-gd2 antibodies
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
DK2694402T3
(en)
|
2011-04-01 |
2017-07-03 |
Mannkind Corp |
BLISTER PACKAGE FOR PHARMACEUTICAL CYLINDER AMPULS
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
WO2012175735A1
(en)
|
2011-06-23 |
2012-12-27 |
Vib Vzw |
A20 inhibitors for the treatment of respiratory viral infections
|
CN103687488B
(zh)
|
2011-06-27 |
2015-06-10 |
帕里昂科学公司 |
化学和代谢稳定的具有钠通道阻滞剂活性的二肽
|
AU2012328885B2
(en)
|
2011-10-24 |
2017-08-31 |
Mannkind Corporation |
Methods and compositions for treating pain
|
EP2822474B1
(en)
|
2012-03-06 |
2018-05-02 |
Ferrosan Medical Devices A/S |
Pressurized container containing haemostatic paste
|
WO2013142038A2
(en)
|
2012-03-23 |
2013-09-26 |
Oxigene, Inc. |
Compositions and methods for inhibition of cathepsins
|
AU2013275758B2
(en)
|
2012-06-12 |
2015-03-12 |
Ferrosan Medical Devices A/S |
Dry haemostatic composition
|
AU2013289957B2
(en)
|
2012-07-12 |
2017-02-23 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
TW201427681A
(zh)
|
2013-01-07 |
2014-07-16 |
Superlab Far East Ltd |
用空間構象改變的重組干擾素治療腫瘤的方法
|
KR102207859B1
(ko)
|
2013-03-15 |
2021-01-27 |
메모리얼 슬로안 케터링 캔서 센터 |
고 친화도 항-gd2 항체
|
EP3587404B1
(en)
|
2013-03-15 |
2022-07-13 |
MannKind Corporation |
Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
|
AU2014283170B2
(en)
|
2013-06-21 |
2017-11-02 |
Ferrosan Medical Devices A/S |
Vacuum expanded dry composition and syringe for retaining same
|
BR112016000937A8
(pt)
|
2013-07-18 |
2021-06-22 |
Mannkind Corp |
formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco
|
JP2016530930A
(ja)
|
2013-08-05 |
2016-10-06 |
マンカインド コーポレイション |
通気装置及び方法
|
JP6489485B2
(ja)
|
2013-12-11 |
2019-03-27 |
フェロサン メディカル デバイシーズ エイ/エス |
押し出し増強因子を含んでいる乾燥組成物
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10286065B2
(en)
|
2014-09-19 |
2019-05-14 |
Board Of Regents, The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
BR112017007466B1
(pt)
|
2014-10-13 |
2021-03-02 |
Ferrosan Medical Devices A/S |
método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
|
US10653837B2
(en)
|
2014-12-24 |
2020-05-19 |
Ferrosan Medical Devices A/S |
Syringe for retaining and mixing first and second substances
|
WO2016149368A1
(en)
|
2015-03-17 |
2016-09-22 |
Memorial Sloan Kettering Cancer Center |
Anti-muc16 antibodies and uses thereof
|
US10918796B2
(en)
|
2015-07-03 |
2021-02-16 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
US20190177421A1
(en)
|
2016-07-15 |
2019-06-13 |
Poseida Therapeutics, Inc. |
Chimeric antigen receptors and methods for use
|
EP3484927A1
(en)
|
2016-07-15 |
2019-05-22 |
Poseida Therapeutics, Inc. |
Chimeric antigen receptors (cars) specific for muc1 and methods for their use
|
CA3043480A1
(en)
|
2016-11-09 |
2018-05-17 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions for adaptive immune modulation
|
CN110267660A
(zh)
|
2016-12-16 |
2019-09-20 |
德克萨斯大学***董事会 |
含布罗莫结构域蛋白4(brd4)的抑制剂
|
EP3574012A1
(en)
|
2017-01-27 |
2019-12-04 |
Memorial Sloan Kettering Cancer Center |
Bispecific her2 and cd3 binding molecules
|
CA3052095A1
(en)
|
2017-01-30 |
2018-08-02 |
Janssen Biotech, Inc. |
Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis
|
MA47442A
(fr)
|
2017-02-07 |
2019-12-18 |
Janssen Biotech Inc |
Anticorps anti-tnf, compositions et méthodes pour le traitement de la spondylarthrite ankylosante active
|
AU2018393110B2
(en)
|
2017-12-20 |
2023-04-27 |
Poseida Therapeutics, Inc. |
VCAR compositions and methods for use
|
KR102019593B1
(ko)
*
|
2018-03-06 |
2019-09-06 |
주식회사 케이티앤지 |
에어로졸 흡입기
|
KR102016848B1
(ko)
*
|
2018-03-06 |
2019-08-30 |
주식회사 케이티앤지 |
흡연 물품용 카트리지 및 이의 에어로졸 흡입기
|
KR102019595B1
(ko)
*
|
2018-03-07 |
2019-09-06 |
주식회사 케이티앤지 |
담배 물질 흡입기
|
WO2019215173A1
(en)
*
|
2018-05-08 |
2019-11-14 |
Societe Industrielle De Sonceboz Sa |
Inhaler
|
AU2019266529A1
(en)
|
2018-05-09 |
2020-12-03 |
Ethicon Inc. |
Method for preparing a haemostatic composition
|
US20190345245A1
(en)
|
2018-05-11 |
2019-11-14 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
US11389433B2
(en)
|
2018-06-18 |
2022-07-19 |
Board Of Regents, The University Of Texas System |
BRD4 inhibitor treatment of IgE-mediated diseases
|
WO2020092845A1
(en)
|
2018-11-01 |
2020-05-07 |
Rigel Pharmaceuticals, Inc. |
Method and composition embodiments for treating acute myeloid leukemia
|
US11712529B2
(en)
|
2018-12-13 |
2023-08-01 |
ResMed Pty Ltd |
Pneumatic block for respiratory pressure therapy device
|
BR112021013903A2
(pt)
|
2019-01-15 |
2021-09-21 |
Janssen Biotech, Inc. |
Composições e métodos de anticorpos anti-tnf para o tratamento da artrite idiopática juvenil
|
WO2020152544A1
(en)
|
2019-01-23 |
2020-07-30 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis
|
CN113840838A
(zh)
|
2019-03-14 |
2021-12-24 |
詹森生物科技公司 |
用于产生抗tnf抗体组合物的制造方法
|
EP3938391A1
(en)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Methods for producing anti-tnf antibody compositions
|
EP3938392A1
(en)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Methods for producing anti-tnf antibody compositions
|
JP2022534020A
(ja)
|
2019-05-23 |
2022-07-27 |
ヤンセン バイオテツク,インコーポレーテツド |
Il-23及びtnfアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
|
WO2020243612A1
(en)
|
2019-05-29 |
2020-12-03 |
Rigel Pharmaceuticals, Inc. |
Method of preventing and treating thrombosis
|
MX2021014882A
(es)
|
2019-06-03 |
2022-03-25 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y métodos para el tratamiento de la espondilitis anquilosante activa.
|
EP3976648A1
(en)
|
2019-06-03 |
2022-04-06 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions, and methods for the treatment of psoriatic arthritis
|
CN114698370A
(zh)
|
2019-08-08 |
2022-07-01 |
里格尔药品股份有限公司 |
用于治疗细胞因子释放综合征的化合物和方法
|
CA3147444A1
(en)
|
2019-08-14 |
2021-02-18 |
Rigel Pharmaceuticals, Inc. |
Method of blocking or ameliorating cytokine release syndrome
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
IL297025A
(en)
|
2020-04-14 |
2022-12-01 |
Poseida Therapeutics Inc |
Preparations and methods for use in cancer treatment
|
WO2021214588A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating coronavirus infections
|
WO2021214587A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating viral infections
|
WO2022026943A2
(en)
|
2020-07-31 |
2022-02-03 |
Pinetree Therapeutics, Inc. |
Neuropilin and angiotensin converting enzyme 2 fusion peptides for treating viral infections
|
WO2023279115A1
(en)
|
2021-07-02 |
2023-01-05 |
Henry Ford Health System |
Compositions comprising endosidin 2 for reducing sars-cov-2 infection
|
US20230042465A1
(en)
|
2021-07-09 |
2023-02-09 |
Janssen Biotech, Inc. |
Manufacturing Methods for Producing Anti-TNF Antibody Compositions
|
AU2022306144A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
WO2023183377A1
(en)
|
2022-03-23 |
2023-09-28 |
Rigel Pharmaceuticals, Inc. |
Pyrimid-2-yl-pyrazole compounds as irak inhibitors
|